Tilray: Canaccord Cuts Price Target To $12 After Q1 Results

On October 7, Tilray Inc (TSX: TLRY) reported their first quarter financial results for the period ending August 31st, 2021. The company reported revenues of $168.02 million for the first quarter, up 43% year over year. The company also posted a net loss of $34.6 million or earnings per share of negative $0.08.

A number of analysts lowered their 12-month price target on Tilray after the results, bringing the average 12-month price target to $14.25, down from $17.45 prior to the results. Tilray currently has 20 analysts covering the stock with 2 analysts having strong buy ratings, 3 have buys, 13 analysts have holds and 2 have sells on the stock. The street high sits at $27 while the lowest comes in at $1.27.

Canaccord Genuity was one of the firms to lower their 12-month price target down to $12 from $17, while reiterating their hold rating on the name. The firm comments that the results came in slightly below consensus, but Tilray maintained their leader position in recreational cannabis at 16% of the market.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Tilray beat Canaccord’s estimate but came in below the $174 million consensus revenue estimate. For the quarter, the company grew revenue 18% quarter over quarter and cannabis revenue grew by “>30%” Canaccord says.

They also add that if you do an “apples to apples” comparison, cannabis revenue would have been flat as the fourth quarter only included 1 month of Tilray’s legacy business. For the company’s distribution segment, which grew 0.6% quarter over quarter, management cites a flood in July that represented lost revenue of about $5 million for the quarter.

For gross profit, Canaccord says that they reported a 30.4% gross profit for the quarter, which was generally in line with estimates but Tilray saw a 1% decline in its cannabis margins. They touch on the increase in expenses but write, “management believes the choppiness in accelerating its adj. EBITDA growth is transitory in nature as it continues to integrate and optimize the legacy Tilray ops into Aphria’s lower cost structure.”

Below you can see Canaccord’s updated estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Curaleaf: Consensus Estimate Falls To $20.18 After Weak Guidance

On March 3rd, Curaleaf Holdings, Inc. (CSE: CURA) reported its fourth quarter and full year...

Friday, March 11, 2022, 04:20:00 PM

Netflix: Analysts Downgrade En Masse Following Weak Subscriber Growth

Last night Netflix (NASDAQ: NFLX) reported their quarterly earnings, which financially, came generally in line...

Wednesday, April 21, 2021, 04:03:00 PM

Equinox: BMO Lowers Price Target To $15.50 Following Q2 Results

On August 4, Equinox Gold Corp. (TSX: EQX) reported its second quarter production results. The...

Thursday, August 5, 2021, 12:43:00 PM

Tilray Sees Gotham Green Look To Sell Recently Acquired Shares

It appears that Gotham Green Partners has approximately zero interest in being a shareholder of...

Monday, September 20, 2021, 08:32:00 AM

Trillion Energy: Research Capital Reiterates $1.35 Price Target

On Tuesday, Trillion Energy (CSE: TCF) announced that it will be expanding its well development...

Sunday, January 15, 2023, 11:23:00 AM